These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome. Borgna-Pignatti C; Bezzi TM; Reverberi R Pediatr Infect Dis J; 1995 Dec; 14(12):1116-7. PubMed ID: 8745031 [No Abstract] [Full Text] [Related]
24. A severe case of cefoxitin-induced immune hemolytic anemia. Leaf DE; Langer NB; Markowski M; Garratty G; Diuguid DL Acta Haematol; 2010; 124(4):197-9. PubMed ID: 21042010 [TBL] [Abstract][Full Text] [Related]
25. Hemolytic anemia from ceftriaxone in an elderly patient: a case report. Imam SN; Wright K; Bhoopalam N; Choudhury A J Am Med Dir Assoc; 2008 Oct; 9(8):610-1. PubMed ID: 19083297 [TBL] [Abstract][Full Text] [Related]
26. Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis. Liu W; Yu D Pediatr Allergy Immunol; 2014 Feb; 25(1):101-2. PubMed ID: 24118095 [No Abstract] [Full Text] [Related]
27. Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness. Tasch J; Gonzalez-Zayaz P Am J Case Rep; 2017 Apr; 18():431-435. PubMed ID: 28428532 [TBL] [Abstract][Full Text] [Related]
28. A case of ceftriaxone-induced haemolysis complicated by acute portal vein thrombosis. Ye W; Liu CW Chin Med J (Engl); 2011 Jan; 124(1):152-4. PubMed ID: 21362324 [TBL] [Abstract][Full Text] [Related]
29. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Garratty G; Postoway N; Schwellenbach J; McMahill PC Transfusion; 1991 Feb; 31(2):176-9. PubMed ID: 1825363 [TBL] [Abstract][Full Text] [Related]
33. Hemolysis from ceftriaxone. Med Lett Drugs Ther; 2002 Nov; 44(1144):100-1. PubMed ID: 12451362 [No Abstract] [Full Text] [Related]
34. Ceftriaxone induced acute multi-organ failure syndrome in a Saudi boy with sickle cell disease. Al-Mendalawi MD Saudi Med J; 2011 Mar; 32(3):320. PubMed ID: 21384076 [No Abstract] [Full Text] [Related]
35. [Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure]. Mulkens CE; van Lochem EG; Folman CC; van der Spek E; van Leeuwen HJ Ned Tijdschr Geneeskd; 2015; 159():A8054. PubMed ID: 25714764 [TBL] [Abstract][Full Text] [Related]
36. Life-threatenting ceftriaxone-induced immune hemolytic anemia in a child with Crohn's disease. Mattis LE; Saavedra JM; Shan H; Shirey RS; Powell E; Oliva-Hemker MM Clin Pediatr (Phila); 2004 Mar; 43(2):175-8. PubMed ID: 15024441 [No Abstract] [Full Text] [Related]
37. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges. Elenga N; Mialou V; Kebaïli K; Galambrun C; Bertrand Y; Pondarre C J Pediatr Hematol Oncol; 2008 Dec; 30(12):928-30. PubMed ID: 19131783 [TBL] [Abstract][Full Text] [Related]
38. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature. Plakogiannis R; Nogid A Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901 [TBL] [Abstract][Full Text] [Related]
39. Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin. Vehapoğlu A; Göknar N; Tuna R; Çakır FB Turk J Pediatr; 2016; 58(2):216-219. PubMed ID: 27976566 [TBL] [Abstract][Full Text] [Related]